Categories /
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
FILE - In this Sunday, March 21, 2021 file photo a man receives a COVID-19 vaccine at a vaccination center in Belgrade, Serbia. Serbia has vaccinated most people with China's Sinopharm jabs, followed by Pfizer, Russia's Sputnik V and recently the AstraZeneca shot. AstraZeneca said Monday March 22, 2021 that advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective. The U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. (AP Photo/Darko Vojinovic)
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.